Treatment of Orthostatic Hypotension
The first-line treatment for orthostatic hypotension should include non-pharmacological interventions such as acute water ingestion, physical counter-pressure maneuvers, compression garments, and increased salt and fluid intake, followed by pharmacological options like midodrine, droxidopa, or fludrocortisone for patients with persistent symptoms. 1
Definition and Diagnosis
Orthostatic hypotension is defined as a decrease in systolic blood pressure ≥20 mmHg or diastolic ≥10 mmHg within 3 minutes of standing from a seated or supine position 1, 2, 3. Diagnosis requires:
- Blood pressure measurements after 5 minutes lying/sitting, then at 1 and 3 minutes after standing
- Documentation of associated symptoms: dizziness, lightheadedness, fatigue, visual disturbances
- Evaluation of electrolytes, renal function, and tests for autonomic cardiovascular neuropathy
Treatment Algorithm
Step 1: Non-Pharmacological Interventions
These should be tried first in all patients:
- Acute water ingestion (Class I recommendation): 16 oz (480 mL) of water for temporary relief 1
- Physical counter-pressure maneuvers (Class IIa recommendation): leg crossing, squatting, muscle tensing 1
- Compression garments (Class IIa recommendation): abdominal binders and lower extremity compression stockings 1
- Increased salt and fluid intake (Class IIb recommendation): 2-3 liters of fluid daily and increased salt intake (6-10 g/day) unless contraindicated 1, 4
- Sleep position modification: Elevate head of bed during sleep to prevent supine hypertension 1
- Meal modifications: Small, frequent meals to minimize postprandial hypotension 1
- Regular exercise: To prevent deconditioning 1
Step 2: Pharmacological Interventions
For patients with persistent symptoms despite non-pharmacological measures:
Midodrine (Class IIa recommendation):
Droxidopa (Class IIa recommendation):
- Dosage: 100-600 mg three times daily, last dose at least 4 hours before bedtime
- FDA-approved for neurogenic orthostatic hypotension 1
Fludrocortisone (Class IIa recommendation):
Additional options for refractory cases (Class IIb recommendation):
Monitoring and Treatment Goals
- Primary goal: Minimize postural symptoms rather than restore normotension 1
- Target BP: <130/80 mmHg for most adults, <130 mmHg for ambulatory older adults (≥65 years) 1
- Regular monitoring: Blood pressure measurements in supine and standing positions to assess treatment effectiveness and monitor for supine hypertension 1
- Follow-up: Every 3 months once stabilized 1
Important Precautions
- Supine hypertension: Monitor carefully, especially with pressor medications like midodrine. Patients should take their last daily dose 3-4 hours before bedtime 1, 5
- Medication interactions: Use caution when combining midodrine with other vasoconstrictors, cardiac glycosides, beta-blockers, or psychopharmacologic agents 5
- Avoid medications that can worsen orthostatic hypotension: opioids, anticholinergics, tricyclic antidepressants 1
- Special populations:
Patient Education
- Inform patients about over-the-counter medications that can elevate blood pressure (cold remedies, diet aids) 5
- Educate about recognizing prodromal symptoms to take preventive actions 1
- Emphasize the importance of avoiding the supine position after taking medications like midodrine 5
By following this structured approach to treating orthostatic hypotension, clinicians can effectively manage symptoms and improve patients' quality of life while minimizing adverse effects.